Cannabis Use Found to Lower Risk of Liver Disease

According to a study published in the journal Progress in Neuro-Psychopharmacology and Biological Psychiatry, cannabis consumption may produce a protective effect against non-alcoholic fatty liver disease (NAFLD). Obesity is a leading cause of increased occurrences of non-alcoholic fatty liver disease (NAFLD).

At the study’s 3-year follow up, it was found that cannabis users presented significantly lower Fatty Liver Index (FLI) scores than non-users, NORML reported.

The authors stated that “cannabis users less frequently met the criteria for liver steatosis than non-users” and that “patients maintaining cannabis consumption after 3 years presented the smallest increment in FLI over time, which was significantly smaller than the increment in FLI presented by discontinuers (p = .022) and never-users (p = .016).”